Evidence map›Paper›PMID 34462532›Full record

ArticleLaboratory investigation; a journal of technical methods and pathology2021

Exosomal tau with seeding activity is released from Alzheimer's disease synapses, and seeding potential is associated with amyloid beta.

Emily Miyoshi, Tina Bilousova, Mikhail Melnik, Danyl Fakhrutdinov, Wayne W Poon, Harry V Vinters, Carol A Miller, Maria Corrada, Claudia Kawas, Ryan Bohannan and 6 more

Open access · hybridAbstract read
In one paragraph

Article in Laboratory investigation; a journal of technical methods and pathology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 56 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Trehalose's untapped mechanisms in alzheimer's: gut-brain-autophagy signalling beyond the usual targets.Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences · 2026
    Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Extracellular Vesicles in Tauopathies: Mechanisms and Applications.International journal of molecular sciences · 2026
    Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 1 country.

Emily Miyoshi *UCLA School of Nursing, UCLA School of Medicine, Los Angeles, CA, USA.ORCID http://orcid.org/0000-0001-8151-0560
Tina Bilousova *UCLA School of Nursing, UCLA School of Medicine, Los Angeles, CA, USA.
Mikhail MelnikUCLA School of Nursing, UCLA School of Medicine, Los Angeles, CA, USA.
Danyl FakhrutdinovUCLA School of Nursing, UCLA School of Medicine, Los Angeles, CA, USA.
Wayne W PoonInstitute for Memory Impairments and Neurological Disorders, UC Irvine, Irvine, CA, USA.ORCID http://orcid.org/0000-0003-0625-3968
Harry V VintersMary S. Easton Center for Alzheimer's Research at UCLA, UCLA School of Medicine, Los Angeles, CA, USA.
Carol A MillerDepartment of Pathology, Keck USC School of Medicine, Los Angeles, CA, USA.
Maria CorradaInstitute for Memory Impairments and Neurological Disorders, UC Irvine, Irvine, CA, USA.
Claudia KawasInstitute for Memory Impairments and Neurological Disorders, UC Irvine, Irvine, CA, USA.
Ryan BohannanInstitute for Memory Impairments and Neurological Disorders, UC Irvine, Irvine, CA, USA.
Chad CarawayInstitute for Memory Impairments and Neurological Disorders, UC Irvine, Irvine, CA, USA.
Chris EliasMary S. Easton Center for Alzheimer's Research at UCLA, UCLA School of Medicine, Los Angeles, CA, USA.
Katherine N MainaMary S. Easton Center for Alzheimer's Research at UCLA, UCLA School of Medicine, Los Angeles, CA, USA.
Jesus J CampagnaMary S. Easton Center for Alzheimer's Research at UCLA, UCLA School of Medicine, Los Angeles, CA, USA.
Varghese JohnMary S. Easton Center for Alzheimer's Research at UCLA, UCLA School of Medicine, Los Angeles, CA, USA.
Karen Hoppens GylysUCLA School of Nursing, UCLA School of Medicine, Los Angeles, CA, USA. kgylys@sonnet.ucla.edu.
University of California, Los Angeles · USUniversity of California, Irvine · USKeck Hospital of USC · US

Funding

Women's CancersP30CA016042 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Samuel Wheeler French · 1985 to 2026
$134.5M
VASCULAR RISK AND COGNITIVE STATUS IN A LATINO POPULATIONP50AG005142 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI BRASKIE, MEREDITH NICOLE · 1985 to 2019
$41.0M
Virology CoreP30AI028697 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI KITCHEN, SCOTT G · 1991 to 2018
$39.9M
UC Irvine Alzheimer's Disease Research Center Induced Pluripotent Stem Cell CoreP50AG016573 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI LAFERLA, FRANK M · 2000 to 2019
$37.0M
Diversity Supplement to R01AG021055; Clinical, Imaging, and Pathological Studies in the Oldest Old: The 90+ StudyR01AG021055 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI CORRADA, MARIA, KAWAS, CLAUDIA H. · 2002 to 2024
$36.9M
The Alzheimer's Disease Research Center at the University of California, IrvineP30AG066519 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI Elizabeth Head · 2020 to 2026
$27.9M
USCADRC Diversity Supplement PachicanoP30AG066530 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI HELENA Chang CHUI, ARTHUR W TOGA · 2020 to 2026
$27.8M
The Aging Brain: Vasculature, Ischemia, and BehaviorP01AG012435 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI VINTERS, HARRY V. · 1994 to 2012
$26.4M
UCLA ALZHEIMERS DISEASE RESEARCH CENTERP50AG016570 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI CUMMINGS, JEFFREY L. · 1999 to 2014
$25.9M
ApoE4-targeted therapeutics that normalize SirT1R01AG051386 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI JOHN, VARGHESE · 2015 to 2019
$3.0M
THE AGING BRAIN-- OXIDANT STRESSR01AG018879 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI MILLER, CAROL A · 2001 to 2005
$1.6M
Tau pathology in neurons, glia, and cell type-specific exosomes from cryopreserved AD cortexR21AG063767 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI BILOUSOVA, TINA, GYLYS, KAREN H · 2020 to 2020
$429k
NCI NIH HHS P30 CA016042NIAID NIH HHS P30 AI028697NIA NIH HHS P01 AG012435NIA NIH HHS P30 AG066519NIA NIH HHS P30 AG066530NIA NIH HHS P50 AG005142NIA NIH HHS P50 AG016570NIA NIH HHS P50 AG016573NIA NIH HHS R01 AG018879NIA NIH HHS R01 AG021055NIA NIH HHS R01 AG051386NIA NIH HHS R21 AG051946NIA NIH HHS R21 AG063767
6 · The paper itself

Abstract

Synaptic transfer of tau has long been hypothesized from the human pathology pattern and has been demonstrated in vitro and in vivo, but the precise mechanisms remain unclear. Extracellular vesicles such as exosomes have been suggested as a mechanism, but not all tau is exosomal. The present experiments use a novel flow cytometry assay to quantify depolarization of synaptosomes by KCl after loading with FM2-10, which induces a fluorescence reduction associated with synaptic vesicle release; the degree of reduction in cryopreserved human samples equaled that seen in fresh mouse synaptosomes. Depolarization induced the release of vesicles in the size range of exosomes, along with tetraspanin markers of extracellular vesicles. A number of tau peptides were released, including tau oligomers; released tau was primarily unphosphorylated and C-terminal truncated, with Aβ release just above background. When exosomes were immunopurified from release supernatants, a prominent tau band showed a dark smeared appearance of SDS-stable oligomers along with the exosomal marker syntenin-1, and these exosomes induced aggregation in the HEK tau biosensor assay. However, the flow-through did not seed aggregation. Size exclusion chromatography of purified released exosomes shows faint signals from tau in the same fractions that show a CD63 band, an exosomal size signal, and seeding activity. Crude synaptosomes from control, tauopathy, and AD cases demonstrated lower seeding in tauopathy compared to AD that is correlated with the measured Aβ42 level. These results show that AD synapses release exosomal tau that is C-terminal-truncated, oligomeric, and with seeding activity that is enhanced by Aβ. Taken together with previous findings, these results are consistent with a direct prion-like heterotypic seeding of tau by Aβ within synaptic terminals, with subsequent loading of aggregated tau onto exosomes that are released and competent for tau seeding activity.

Indexed as

AgedAged, 80 and overAlzheimer DiseaseAmyloid beta-PeptidesAnimalsCerebral CortexExtracellular VesiclesFemaleHumansMaleMiceMiddle AgedProtein Aggregation, PathologicalSynapsesSynaptosomestau ProteinsAmyloid beta-Peptidestau Proteins

Identifiers

PMID34462532
PMCPMC8590975
OpenAlexW3198547687

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.